AC Immune (ACIU) Shareholder's Equity Growth (1y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -56.18% |
| Sep 30, 2025 | -48.04% |
| Jun 30, 2025 | -33.85% |
| Mar 31, 2025 | -36.39% |
| Dec 31, 2024 | -29.23% |
| Sep 30, 2024 | 5.60% |
| Jun 30, 2024 | -11.92% |
| Mar 31, 2024 | 0.25% |
| Dec 31, 2023 | 3.24% |
| Sep 30, 2023 | -27.71% |
| Jun 30, 2023 | -26.41% |
| Mar 31, 2023 | -28.69% |
| Dec 31, 2022 | -30.27% |
| Sep 30, 2022 | -99.90% |
| Jun 30, 2022 | -99.90% |
| Mar 31, 2022 | -99.90% |
| Dec 31, 2021 | 5.55% |
| Sep 30, 2021 | 76,934.22% |
| Jun 30, 2021 | 79,630.17% |
| Mar 31, 2021 | 83,447.75% |
| Dec 31, 2020 | -13.41% |
| Sep 30, 2020 | -14.61% |
| Jun 30, 2020 | 95,421.37% |
| Mar 31, 2020 | 13.08% |
| Dec 31, 2019 | 54.23% |
| Dec 31, 2018 | 50.71% |
| Dec 31, 2017 | -16.83% |
| Sep 30, 2017 | 1.38% |
| Jun 30, 2017 | -1.52% |
| Mar 31, 2017 | 19.15% |
| Dec 31, 2016 | 98.33% |
| Sep 30, 2016 | 69.23% |
| Dec 31, 2015 | 194.84% |